Ex vivo transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of rapamycin therapy prolongs free flap allograft survival

Plastic and Reconstructive Surgery

Volumn 127, Issue 5, 2011, Pages 1820-1829

  Xiao, Bo ^a   Xia, Wei ^a   Zhao, Kefeng ^a   Yang, Yang ^a   Fu, Su ^a   Li, Yang ^a   Liu, Bei ^a   Guo, Shuzhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; DNA; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BROWN NORWAY RAT; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FREE TISSUE GRAFT; GENE EXPRESSION; GENE TRANSFER; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INGUINAL REGION; LEWIS RAT; MALE; POLYMERASE CHAIN REACTION; RAT; SKIN TRANSPLANTATION; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; FREE TISSUE FLAPS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; GRAFT SURVIVAL; GROIN; IMMUNOCONJUGATES; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED BN; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; SIROLIMUS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79955649675     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31820cf264     Document Type: Article

References (39)

1. Whitaker IS, Duggan EM, Alloway RR, et al. Composite tissue allotransplantation: A review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg. 2008; 61:481-492. (Pubitemid 351635903)
2. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: Early report. Lancet 2006;368:203-209. (Pubitemid 44037773)
3. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008;372:631-638.
4. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008;372:639-645.
5. Madani H, Hettiaratchy S, Clarke A, Butler PE. Immunosuppression in an emerging field of plastic reconstructive surgery: Composite tissue allotransplantation. J Plast Reconstr Aesthet Surg. 2008;61:245-249. (Pubitemid 351215147)
6. Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus- mediated CTLA4Ig expression. J Immunol. 2000;164: 5258-5268. (Pubitemid 30305204)
7. Michaels J 5th, Levine JP, Hazen A, et al. Biologic brachytherapy: Ex vivo transduction of microvascular beds for efficient, targeted gene therapy. Plast Reconstr Surg. 2006;118: 54-65. (Pubitemid 44324167)
8. Olthoff KM, Judge TA, Gelman AE, et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med. 1998;4:194-200. (Pubitemid 28137374)
9. Yang Z, Rostami S, Koeberlein B, Barker CF, Naji A. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Transplantation 1999;67: 1517-1523. (Pubitemid 29315672)
10. Miao G, Ito T, Uchikoshi F, et al. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft. Transplantation 2004;78:59-64.
11. Bluestone JA, St Clair EW, Turka LA. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity 2006; 24:233-238.
12. Solari MG, Washington KM, Sacks JM, et al. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model. Plast Reconstr Surg. 2009;123:17s-25s.
13. Petry JJ, Wortham KA. The anatomy of the epigastric flap in the experimental rat. Plast Reconstr Surg. 1984;74:410-413. (Pubitemid 14065513)
14. Cendalesa LC, Kanitakisb J, Schneebergerc S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396-1400.
15. Noris M, Azzollini N, Mister M, et al. Peripheral donor leukocytes prolong survival of rat renal allografts. Kidney Int. 1999;56:1101-1012.
16. Bluestone JA. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 1995;2:555-559.
17. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992;71:1065-1068. (Pubitemid 23016541)
18. Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev. 2009;229:271-293.
19. Snanoudj R, de Préneuf H, Créput C, et al. Costimulation blockade and its possible future use in clinical transplantation. Transpl Int. 2006;19:693-704. (Pubitemid 44196157)
20. Azuma H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad SciUS A. 1996;93:12439-12444. (Pubitemid 26367162)
21. Blazar BR, Taylor PA, Linsley PS, et al. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 1994;83:3815-3825. (Pubitemid 24175574)
22. Shiraishi T, Yasunami Y, Takehara M, et al. Prevention of acute lung allograft rejection in rat by CTLA4Ig. Am J Transplant. 2002;2:223-228. (Pubitemid 36330239)
23. Gilson CR, Milas Z, Gangappa S, et al. Anti-CD40 monoclonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation. J Immunol. 2009;183:1625-1635.
24. Ierino FL, Mulley W, Dodge N, et al. Dendritic cells expressing soluble CTLA4Ig prolong antigen-specific skin graft survival. Immunol Cell Biol. 2010;88:846-850.
25. Wang Y, Wei H, Ni Y, et al. Transgenic expression of cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin prolongs xenogeneic skin graft survival without extensive immunosuppression in rat burn wounds. J Trauma 2008;65:154-162.
26. Hancock WW, Sayegh MH, Zheng XG, et al. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA. 1996;93:13967-13972. (Pubitemid 26424229)
27. Groenewegen G, Buurman WA, Jeunhomme GM. Alloantigen presentation by canine endothelial cells: Presentation of autologous alloantigens in vitro. Transplantation 1986;41: 751-754. (Pubitemid 16062692)
28. Wagner CR, Vetto RM, Burger DR. The mechanism of antigen presentation by endothelial cells. Immunobiology 1984; 168:453-469. (Pubitemid 15153379)
29. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection. J Exp Med. 1990;171:307.
30. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27. (Pubitemid 44116697)
31. Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell 2008;133:775-787. (Pubitemid 351707693)
32. Tomasoni S, Azzollini N, Casiraghi F, et al. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol. 2000;11:747-752. (Pubitemid 30171884)
33. Silverman MS, Chin PH. Differences in the rejection of skin transplants and blood cells of donor marrow origin by radiation- induced chimeras. Ann N Y Acad Sci. 1962;99:542-549.
34. Boyse EA, Old LJ. Loss of skin allograft tolerance by chimeras. Transplantation 1968;6:619.
35. Calne RY, Collier DS, Lim S, et al. Rapamycin for immunosuppression in organ allografting. Lancet 1989;2:227.
36. Hendrikx TK, Velthuis JH, Klepper M, et al. Monotherapy rapamycin allows an increase of CD4+ CD25bright+ FoxP3+ T cells in renal recipients. Transpl Int. 2009;22:884-891.
37. Kanaya K, Tsuchida Y, Inobe M, et al. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 2003;75:275-281. (Pubitemid 36222949)
38. Zamir G, Gelman AE, Olthoff KM, et al. Patterns of transgene expression and viral clearance from the transplanted liver following ex vivo adenovirus-mediated gene transfer. J Hepatol. 2004;41:714-720. (Pubitemid 39434299)
39. Bagley J, Iacomini J. Gene therapy progress and prospects: Gene therapy in organ transplantation. Gene Ther. 2003;10: 605-611. (Pubitemid 36553605)